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ABSTRACT Aging leads to changes in the relative
proportions of several functionally distinct T cell sub-
sets, including increases in the proportions of mem-
ory cells in the CD4 and CD8 subsets and in the
proportion of T cells expressing the multiple-drug
resistance pump P-glycoprotein. To see whether in-
dividual differences in T cell subset levels predict life
span, we measured the levels of five age-sensitive T
cell subsets, at 8 and again at 18 months of age, in
the peripheral blood of genetically heterogeneous
mice bred as the progeny of CB6F1 females and
C3D2F1 males. The strongest immunological predic-
tor of life span in univariate regression analyses was
the proportion of CD4 memory cells measured at 18
months of age (P=O.003). CD4 memory cell
levels remained strongly correlated with life span
(P<O.0003) in a multiple regression analysis after ad-
justment for sex. The proportion of CD4 cells ex-
pressing P-glycoprotein was also correlated with life
span (P<O.O1), but only in male mice. Weaker rela-
tionships were observed between life span and 8-
month tests of CD8 memory and CD8 P-glycoprotein
levels, for CD4 naive cells at 18 months, and for the
change in CD4 naive cells between 8 and 18 months
of age; these were, however, near the margin of sta-
tistical significance and could reflect chance relation-
ships. The relationship between CD4 memory cell
levels and life span was similarly strong regardless of
the cause of death in mice whose death was attribut-
able to lymphoma, fibrosarcoma, mammary card-
noma, and other forms of terminal pathology.
Additional work is needed to discriminate between
two hypotheses: 1) that high levels of CD4 memory
cell themselves predispose to disease and early death,
particularly from neoplasia; or 2) that accumulation
of CD4 memory cells is a biomarker of some under-
lying process-perhaps accelerated aging-that it-
self leads to early mortality.-Miller, R. A., Chrisp,
C., Galecki, A. CD4 memory T cell levels predict life
span in genetically heterogeneous mice. FASEBJ. 11,
775-783 (1997)
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THE RELATIONSHIPS AMONG IMMUNE STATUS, aging,
and cancer are complex and controversial. Although
it is clear that for most kinds of cancer the incidence
of risk increases dramatically in the second half of
the life span, the suggestion that diminished immune
responsiveness contributes to the increased cancer
risk of the elderly is highly controversial. Patients
whose immune systems are weakened by congenital
abnormalities, ablative chemotherapy or radiation
therapy, or HIV infection are indeed put at higher
risk for cancer than normal controls, but the forms
of neoplasia typically seen in these settings are un-
usual, restricted typically to hematopoietic malignan-
cies and a few other tumors not commonly seen in
the elderly. The speculation that the immunodefi-
ciency of aging might contribute to increased tumor
incidence in aged individuals rests at present on in-
direct and unconvincing evidence. A few studies (1-
4) of very old humans have suggested that immune
anergy may be associated with an increased risk of
mortality in fairly short periods of follow-up (rarely
longer than 5% of the mean life span); however,
these studies have not discriminated between neopla-
sia and other causes of death, and have often either
failed to reach statistical significance (3) or to adjust
for the confounding effects of age on both anergy
and life expectancy (1, 2). Because people are so
long-lived, it is very expensive to perform studies in
which a substantial fraction of the life span elapses
between a potentially prognostic test and the diag-
nosis of a lethal illness; studies with only short-
term follow-up are potentially confounded by the
possibility that the illness itself may have altered the
outcome of the test in question.
In mice and humans, aging leads to progressive
changes in T lymphocyte subsets. In both species,
memory T cells increase in their relative proportions
whereas naive or virgin T cells decline in parallel (5-
8). The shift from virgin to memory T cell subsets
affects both the CD4 and CD8 T cell subsets. In mice,
there is also an increase with age in the proportion
of CD4 and CD8 T cells that express the plasma
membrane pump P-glycoprotein; the increase in
these CD4P and CD8P cells affects both the naive and
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memory cell subsets (9). The accumulation of mem-
ory cells and of cells that express P-glycoprotein may
account for some elements of age-associated decline
in T cell proliferation and cytokine production in
vitro (6, 10-12), but it is not yet clear whether or in
what way T cell subset shifts contribute to age-asso-
ciated changes in in vivo immune responses. Never-
theless, the changes with age in T cell subset
distribution, together with the demonstrable differ-
ences between subsets in in vitro responsiveness, sug-
gest the testable hypothesis that measurements of T
cell subset distributions might provide information
about interindividual differences in protective im-
munity and susceptibility to late-life illnesses, includ-
ing neoplastic diseases.
To test this idea, we carried out a study of T cell
subsets, longevity, and pathology in mice. Although
most previous work on aging mice has involved ge-
netically homogeneous groups of animals-typically,
inbred lines or their Fl hybrids-we chose instead to
use mice bred via a four-way cross-breeding scheme
(13) that can produce an arbitrarily large number of
genetically distinct mice, all of which share the same
four grandparents and are thus the genetic equiva-
lent of one extremely large sibship. We report here
that one of the T cell subset tests-specifically, the
proportion of CD4 cells expressing the memory cell
marker CD44 in 18-month-old mice-has a signifi-
cant ability to predict longevity. Consistent with our
hypothesis, mice with high levels of CD4 memory
cells-whose immune system thus resembles that of
older mice-tend to have relatively short life expec-
tancy compared to sibs with lower levels of CD4 mem-
ory T cells. The relationship between CD4 memory
cell levels and longevity holds for mice whose death
is attributable to any of several kinds of neoplasia in-
cluding lymphoma, fibrosarcoma, and other cancers.
MATERIALS AND METHODS
Mice and husbandry
Mice for this study were the progeny of a cross between CB6F1
females and C3D2F1 males; each mouse in the group is thus
genetically distinct, but shares all four grandparents with every
other mouse. The population is thus the genetic equivalent of
a very large sibship. We refer to the offspring of this genetic
cross as UM-HET3 mice. They were housed in same-sex groups
in one room of a specific pathogen-free colony. Each cage was
protected by a microisolator top to minimize cage-to-cage
spread of infectious agents. To verify the pathogen-free status
of the colony, sentinel mice (not part of the experimental
group) were exposed to spent bedding collected from all of
the test mice, and then later tested serologically for antiviral
titers and evidence of pinworm. These screening tests were
carried out every 3 months and were repeatedly negative
throughout the course of this study. Mice were given free ac-
cess to rodent chow and water. Mice were inspected at least
once/day (twice/day except on weekends) and weighed
monthly. Mice judged to be potentially ill were placed on a
“watch list” and were weighed at least weekly and inspected
at least twice a day 7 days/wk.
Exclusion criteria
The cohort of mice used for this analysis originally contained
173 animals, of which 90 were male and 83 were female. These
mice were all born between September 14, 1993 and February
16, 1994. Six cages containing male mice were eliminated
from the study because fighting had led to bite wounds; all 22
males in such cages were culled at ages of less than 12 months,
and these animals are not included in the statistical analyses.
In addition, 18 males were found, at necrosy to be suffering
from mouse urinary syndrome (“MUS”), a syndrome char-
acterized by obstruction of the urethra with expansion and
(in extreme cases) rupture of the urinary bladder, which has
previously been observed in group-housed males of several
inbred strains (14, 15) and is thought to represent a response
to the social stresses that arise in all-male groups. These males
were also excluded from all analyses; their mean age at death
was 15.6 ± 4.2 (Sn) months. Four other males were also ex-
cluded from the study: one because it was killed in error at
the age of 18.7 months, and three others because they died
spontaneously before 8 months of age and thus did not yield
any immunological data. The population of mice in the study
included 46 males and 83 females, among which 41 males and
79 females survived to the 18-month assay point.
Assessment of T cell subsets
These procedures have been described in greater detail else-
where (16). In brief, 400 p.1 blood samples were taken from
each mouse at 8 months of age and again at 18 months. Each
sample was divided into eight aliquots and tested for T cell
subset representation by using combinations of monoclonal
antibodies and/or fluorescein-tagged latex beads. Table 1
summarizes the eight subsets tested at each age. A small per-
centage of the assays were deemed to be unreliable on tech-
nical grounds and these were not used in the analyses.
Necropsy
Mice were judged to be moribund if, in the judgment of an
experienced technician, they were considered unlikely to sur-
vive for more than another few days. This assessment was
based on a constellation of signs including continued or se-
vere weight loss, hunched posture, poor grooming, failure to
eat or drink, extreme lethargy or partial paralysis, or the pres-
ence of a large ulcerated tumor. Mice judged to be moribund
were killed and subject to necropsy, as were mice found dead
in their cages. All of the mice killed when moribund were
found at necropsy to have pathological signs of advanced ill-
ness. The adoption of this “sacrifice when moribund” strategy
greatly increases the proportion of animals that yield high-
quality necropsy data, but poses the potential risk of under-
estimating the life span in animals killed before their natural
death. The mean age at death of mice killed when moribund
was 28 months (sD=4 months; N=85), which is significantly
higher than the age at death of those found to die spontane-
ously (25±6; N=44; F=9.00; P=0.003 by the Student-Newman-
Keuls test). The difference in life span between these two
groups of mice might reflect differences in age of incidence
between diseases that kill quickly and those that lead to grad-
ual morbidity before demise. The data do not, however, sup-
2Abbreviations: MUS, mouse urinary syndrome; CD4M[8],
refers to the CD4M determination made at 8 months of age.
TABLE 1. T cell subsets tested in 8- and 18-month old UM-HET3 mice
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Antibody Description Calculation
CD3 T cells Cell number per microliter of blood
CD4 Class II restricted (“Helper”) T cells CD3(+), CD4(+) as percentage of CD3
CD8 Class I restricted (“cytotoxic”) T cells CD3(+), CD8(+) as percentage of CD3
CD4M Memory CD4 cells CD4(+), CD44(+) as percentage of CD4
CD8M Memory CD8 cells CD8(+), CD44(+) as percentage of CD8
CD4V Virgin CD4 cells CD4(+), CD45RB(low) as percentage of CD4
CD4P P-glycoprotein(+) CD4 cells CD4(+), R123-extruding as percentage of CD4
CD8P P-glycoprotein (+) CD8 cells CD8 ( +), Ri 23-extruding as percentage of CD8
port the idea that this strategy leads to a serious
underestimation of longevity.
Details of the methods used to assess pathological lesions
have been described in detail earlier (13). All slides were ex-
amined and all were diagnoses made by the same pathologist
(C. Chrisp). Although most mice had various conditions not
usually seen in young animals, it was almost always possible for
the pathologist to identify one (or occasionally two) form of
serious illness that very likely caused death or, for moribund
animals, the severe illness that had led to the death of the
mouse. The necropsy data were used to divide the mice into
subgroups according to major cause of death. These suh-
groups consisted of death due to 1) fibrosarcoma; 2) lym-
phoma; 3) mammary tumor; 4) other forms of neoplasia; 5)
nonneoplastic illness; and 6) cause undetermined. The lym-
phoma group included several histologically distinct forms
such as follicular center cell, small lymphocytic, and lympho-
blastic lymphomas. The “other neoplastic” group included
cases of pulmonary adenocarcinoma, hepatocellular carci-
noma, histiocytic sarcoma, pituitary adenoma, and several
rarer lesions. Nonneoplastic illnesses included congestive
heart failure, glomerular amyloidosis, endometritis,jejunal in-
tussusception, middle ear hemorrhage, and pyometra. Of the
11 mice in the “undetermined” group, five had suffered se-
vere postmortem autolysis; in the other six, it proved impos-
sible to assign a probable cause of death from among the
multiple lesions found at necropsy.
Statistical analysis
The dependent variable used in the analysis was life span. In-
dependent variables included gender and T cell subsets mea-
sured at 8 and 18 months. When the analysis was performed,
one mouse was still alive (censored observation) and it was
excluded from calculations. The analysis was performed in two
steps. In the first exploratory step, simple univariate regression
models were considered to study the effect of gender and T
cell subsets on life span. In the second step, several multiple
regression models were considered that correspond to a clas-
sical analysis of covariance. The second stage allowed us to
take into account the potential confounding effect of gender
on the relationship between T cell subsets and life span. In
addition, interaction terms between gender and various CD4
memory T cell variables allowed us to determine whether the
relationship between the immunologic variables and life span
was the same in both gender groups.
A similar approach was used to study the relationship be-
tween CD4M[18] and life span in subgroups differing in
their cause of death. To develop the best model (life
span = sex +cd4M [18]), several pairs of nested models were
compared using F-test statistics. The model fit was checked for
individual and systematic departures of the observed and fit-
ted values by using informal (e.g., inspection of residuals) and
formal methods [e.g., based on score tests for extra parame-
ters (17)].
Calculations were performed by using PROC REG and
PROC GLM in SAS/STAT. Values of P < 0.05 were con-
sidered to be significant.
RESULTS
Our working hypothesis was that one or more of the
T cell subset markers would prove to have prognostic
significance, and specifically that there would be a
relationship between the marker (or markers) and
life span. Some of the T cell subsets-the CD4M,
CD8M, CD4V, CD4P, and CD8P populations-have
been shown in previous cross-sectional analyses to
change with age. Since CD4M, CD8M, CD4P, and
CD8P all increase with age, our prediction was that
mice with high values of these cells at any given age
would have a relatively short life span. CD4V values
tend to decline with age, and we therefore hypothe-
sized that low CD4V values would be correlated with
a short life span. Although reports of the effects of
age on mouse CD4 levels are less consistent, several
published studies (18, 19), including our own of a
separate UM-HET3 population (20), have shown a
decline with age in the proportion of CD4 cells in
mouse blood; we therefore predicted that if CD4 lev-
els showed a relationship with life span, it would be
one in which low GD4 levels predicted short life span.
To explore these ideas, we first calculated the re-
gression coefficients for each of the 16 subset mea-
surements (eight tests at each of two ages). Table 2
shows the calculated regression coefficients, t statis-
tics, and the significance of the effect in a two-tailed
procedure for all cases in which p(t) < 0.10. The
strongest predictor among the immune status tests
was CD4M[18]. The regression coefficient, -2.43,
had a sign consistent with the hypothesis that large
CD4M[18] values would be correlated with short life
span. Sex was also a significant predictor, with female
mice longer-lived than males. There were also mar-
ginally significant relationships between life span and
CD8M[8], CD8P[8], CD4P[18], and CD4V[18], and
with the change in CD4V between 8 and 18 months
of age; these had much less predictive power, and
some are likely to represent chance relationships of-
ten seen in a series of multiple comparisons. The pa-
TABLE 2. Predictors of l[espan l univariate regression
‘(8 to 18
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Regression
Variable Time coefficient t p(t)
Sex” (NA)” -88 -3.35 0.0011
CD8M 8 -2.28 -1.91 0.059
CD8P 8 2.04 1.95 0.054
CD4M 18 -2.43 -3.05 0.0029
CD4P 18 -1.79 -1.93 0.056
CD4V 18 1.22 1.71 0.090
LCD4Vr (NA) 2.25 1.96 0.056
“Male = 1; female = Not applicable.
nsonths).
rameter estimates for CD4M, CD8M, CD4P, and
CD4V have the sign predicted by the hypothesis,
since the former three subsets increase whereas
CD4V cells decline with age. Our working hypothesis
predicted that high CD8P levels should be correlated
with short life span, but we note that the marginally
significant relationship between CD8P and life span
(Table 2) is opposite to the predicted direction.
These univariate calculations are exploratory; the re-
sults are not adjusted for multiple comparisons, and
so require cautious interpretation.
To see whether stratification by sex might reveal
relationships between T cell markers and life span
that had been obscured by combining males with fe-
males for the initial regression estimates, we plotted
life span vs. T cell subset levels separately for males
and females for each of the 16 T cell assays. In most
cases, this recalculation of the regression results did
not reveal significant relationships not already appar-
ent from analysis of the pooled data. The exception
was the relationship between CD4P[18] and life span,
which was much stronger in male than in the female
mice: for males the regression coefficient for
CD4P[18] was -4.38 (t= -2.72; P=0.01), whereas for
females the regression coefficient was 0.20 (t=0.18;
P=0.86).
Figure 1 shows the scatterplots for the six relation-
ships that were at least marginally significant (at
P<0.1). The scatterplots show that the relationships
suggested by the coefficients collected in Table 2 ap-
pear to apply to both males and females (except for
the CD4P[18J values, as noted above) and that the
relationships are not attributable to a small number
of unusual outlying individuals.
We next used multiple linear regression to calcu-
late the best fit of our data to a model in which sex
and T cell determinations predict longevity. The best-
fit model yielded F = 11.96 (P<0.0001). Only sex and
CD4M[18] met the threshold for inclusion in the
model. Table 3 shows the best-fit parameters and
their statistical significance. R2 for the model was
0.18; thus, 18% of the variance in life span could be
accounted for by differences among mice in sex and
CD4M[18].
The calculations just presented suggest that high
CD4M levels at 18 months of age are correlated with
relatively low life expectancy. It is possible that such
a relationship might reflect an effect of CD4M levels
on the development of a specific kind of late-life dis-
ease. Alternately, high CD4M levels might be caused
by the early stages of some specific disease process.
To test these ideas, we calculated the regression co-
efficients for CD4M[18] by using the multiple re-
gression procedure illustrated in Table 3 separately
for mice in each of five groups stratified by principal
cause of death. The results are shown in Table 4,
which presents the regression coefficients after ad-
justment for sex. The parameter estimates for each
of the three distinct neoplastic causes of death and
for the “other neoplasia” category are similar to one
another and to the coefficient (-2.88) calculated for
the entire group of mice. This suggests that
CD4M[18] has an approximately equal effect on life
span regardless of the cause of death, at least for
deaths attributable to neoplasia. The parameter es-
timate for the small number of mice whose deaths
were attributable to nonneoplastic lesions (-1.65;
N=13) is consistent in sign with the other values
shown in Table 4, but lower than that for the other
categories; it does not approach statistical signifi-
cance. A multiple regression model in which life span
was estimated on the basis of sex, CD4M[18], a term
indicating the presence or absence of neoplastic
death, and the [CD4MXneoplasm] interaction term
yielded an estimate for the CD4M[18] parameter
(-2.37; t-2.46; p(t)”0.016) not greatly different
from that shown in Table 3. The interaction term
itself was not significant (parameter=-0.54,
t=-0.28; p(t)=O.78), consistent with the idea that
the relationship of life span with CD4M[18] was not
significantly different in mice that did or did not de-
velop a fatal neoplasm; however, the sample size is
small enough that an effect of this kind might have
gone undetected. The term for neoplastic death did
not have any significant effect in this model, i.e., it
did not contribute significantly to the variance in life
span. Additional studies, including larger numbers of
animals with other causes of death, will be needed to
decide whether CD4M[18] values have prognostic
significance for nonneoplastic deaths.
DISCUSSION
Several previous attempts have been made to predict
longevity or disease risk by tests of age-sensitive im-
mune status indices. The long life of humans makes
it difficult to perform a study in which more than a
small fraction of the life span elapses between the
time of testing and the eventual demise of the tested
subjects. Several studies of very old humans have doc-
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Figure 1. Plots of T cell subset counts against lifespan for the assays listed in Table 2. Each point represents a single mouse.
Males are shown as open circles and females as filled circles. The lines shown (bold for females) are derived from the multiple
regression equation calculating life span as a function of sex, the T cell subset, and, where significant, the [sexXsubset] inter-
action term.
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TABLE 3. Predictors of ly’espan using multiple regression
Variable Regression coefficient t p(t) <
Sex” -84.1 -3.69 0.0004
CD4M[18] -2.88 -3.77 0.0003
“Male = I; female = 0.
or poor mitogen responsiveness (2) and low subse-
quent survival.
The first of these studies was based on a cohort of
52 nursing home residents, all of whom were more
than 80 years of age, and included only a 2-year fol-
low-up period; none of the 34 deaths were attribut-
able to cancer. The second study monitored 403
elderly apartment-dwellers, initially of average age 86,
for a 25-month follow-up; seven of the 61 deaths were
due to malignancy. Neither study tested the hypoth-
esis that the relationship between immune nonre-
sponsiveness and mortality risk reflects the common
dependence of both results on the age of the subject,
and neither study convincingly refutes the idea that
preexisting illness may have contributed both to poor
immunity and high mortality risk. A third group (4)
has reported an association between poor 2-year sur-
vival and a cluster of immune indices (high numbers
of CD8 cells, low numbers of CD4 cells, low B cell
numbers, and low responses to T cell mitogens) in a
group of 102 very old individuals (age range 86-92).
A fourth study (3) tested the relationship between
skin tests for delayed hypersensitivity and longevity in
a group of 293 apparently healthy elderly persons (av-
erage age of 72 years), with a 9-year follow-up period.
Skin test anergy predicted relatively poor survival, but
the effect was of marginal significance (P=0.06) after
adjustment for subject age (95% confidence interval
0.94-3.79 for all-cause mortality). In this population,
there was also a trend for anergy to be associated with
increased risk of death from cancer (relative risk
2.65; 95% confidence interval 0.74-9.55); there was
little evidence for an association between anergy and
increased risk of cancer incidence (relative risk of
1.15). Together, these reports suggest that poor im-
mune responsiveness may be associated with low sur-
vival in very old humans, but more information is
needed about the robustness of the effect, the influ-
ence of potential confounders (sex, age, preexisting
illness), effects on specific forms of illness (including
neoplasia), and the prognostic value of tests admin-
istered to younger individuals.
In principle, similar questions could be explored
in rodents well before the end of their life span, but
the difficulties in assessing immune status without
harm to the animal have been an obstacle. Boersma
et al. (18) have reported that the proportion of
CD8 (+) cells among peripheral blood T cells pre-
dicted remaining life span in CBA mice at any age
tested; high levels of CD8 cells were associated with
high mortality risk. No such relationship was observ-
able in C57BL/6 mice, however, and the dramatic
increase with age in the proportion of T cells express-
ing the CD8 marker seen by this group (18) is not
typical of most other studies of inbred (21) or genet-
ically heterogeneous (20) mice. An interesting study
(22) of mice bred as a backcross between genetically
heterogeneous lines differing in early life humoral
immunity reported that those animals with highest
anti-erythrocyte antibody responses at 8 wk of age
were also likely to have the greatest longevity. Neo-
plasia was found in 18% of the 102 mice taken to
necropsy; however, infectious disease is likely to have
been a prominent cause of death in this conventional
(i.e., not specific pathogen-free) colony, and thus the
data do not provide much insight into possible links
between immune responsiveness and late-life neo-
plastic disease.
A study of four-way cross mice (23) found that
death from lymphoma within the first 18 months of
life was associated with high levels of CD4M, CD8M,
CD8, and CD4V cells tested at 6 months of age. This
study, however, had several weaknesses. First, specific
pathogen-free status was lost when the mice were 14
months old, and it is possible that the relationship
between immunity and longevity may have been com-
plicated by infection. Second, the grandparents used
to generate the four-way cross included two strains,
AKR/J and SJL/J, which themselves have an unusu-
ally high rate of neoplasia in early life. Third, the
housing method used (one mixed-sex pair per cage)
tends to shorten life span in the multiparous females;
the relationship between immune markers and early
tumor death could have reflected differences be-
tween males and females in both outcomes. Last, the
results, though statistically significant, were based on
only five deaths in a population of only 40 mice. The
current protocol was designed in part to avoid these
potential confounders by removing AKR/J and SJL/J
from the breeding system, increasing the numbers of
subjects of both sexes, using virgin animals, careful
maintenance and documentation of specific patho-
gen-free status, and continuing the study until the
death of all animals in the cohort.
The CD4M subset has been shown to increase with
age in cross-sectional studies of mice (5, 6, 19) and
TABLE 4. Prediction of lfespan t CD4M(18) after adjust
for sex in subgroups with dffesing causes of death
ment
Regression
Cause of death coefficient N t p(t)
Fibrosarcoma -3.92 17 -1.92 0.076
Lymphoma -2.89 28 -2.11 0.045
Mammary carcinoma -4.66 11 -1.05 0.325
All other neoplasms -2.86 41 -2.12 0.041
Nonneoplastic causes -1.65 13 -0.59 0.567
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humans (7, 24). A longitudinal study of UM-HETS
mice also showed (20) increases in the CD4M subset
in both male and female animals; the proportion of
CD4 cells in the CD4M subset declined by 4.5 per-
centage points (±2.2 SEM; N=59) between 8 and 14
months of age, and another 6.3 (± 1.9; N=48) per-
centage points between 14 and 20 months of age.
Since high levels of CD4M cells are characteristic of
older mice, we predicted that within a group of mice
at a given age, those with the highest levels of CD4M
cells would be more susceptible to late-life illness.
The data show that high CD4M levels at 18 months
of age are indeed characteristic of mice destined to
die relatively soon. An increase of 14 percentage
points in the CD4M level (one standard deviation) is
associated in this population with a decline of 40.9
days of life expectancy, i.e., about 5% of the mean or
median life span.
We can consider three classes of explanations for
this correlation: 1) disease leads to changes in CD4M
levels as well as life span; 2) CD4M levels reflect im-
mune competence, which in turn alters incidence or
progression of disease; and 3) CD4M levels reflect the
pace of a process, such as aging, that influences dis-
ease risk and longevity.
The first of these ideas would attribute the accu-
mulation of CD4M cells in some particular mice to
an underlying disease state, such as neoplasia, that
also leads to the relatively rapid death of the animal.
Although this is hard to rule out entirely, we consider
it unlikely for two reasons. First, the relationship be-
tween CD4M and longevity is seen in mice dying of
diverse causes. Lymphomas, fibrosarcomas, and
mammary adenocarcinomas are sufficiently common
in these animals to justify stratification into separate
classes; in each case, as well as for the large group of
“miscellaneous” other neoplasms, the regression co-
efficient is of roughly equal size. The strength of the
relationship may well be slightly less for deaths from
nonneoplastic causes, but it will be difficult to test this
idea until larger numbers of animals are evaluated.
None of these illnesses is known to induce an in-
crease in peripheral blood CD4M levels in mice or
humans. It is possible that one of these forms of dis-
ease systematically increases CD4M values through an
unknown mechanism, but it seems less likely that all
would do so and to a similar extent. Second, cross-
sectional studies of 18-month-old mice rarely find
morphologic evidence of malignancy at this compar-
atively early age (25). The mean interval between
blood sampling and death in this study was 9.6
months, or about one-third of the mean life span.
Any preneoplastic process putatively responsible for
the alteration in CD4M [18] levels would have to be
sufficiently far advanced at 18 months to lead to the
immune alteration, and yet sufficiently immature so
as not to lead to death or severe illness for many ad-
ditional months.
A second possible explanation for our findings
would be that alterations in immune function, de-
tectable by CD4M counts, lead to an increased risk
for tumor incidence or progression. The idea that
poor immune function contributes to cancer risk
(the immune surveillance hypothesis) has become
less popular in the face of evidence that the spec-
trum of tumors seen in congenital or iatrogenic
forms of immune deficiency is quite different from
that seen in old age (26). There is, however, very
little evidence for or against the idea that the form
of immune deficiency seen in normal aging, in-
cluding a shift in the proportions of memory and
naive cells, would alter host defenses against neo-
plasia. Our correlational data, though consistent
with a cause-and-effect relation between immuno-
senescence and neoplastic disease, certainly do not
prove such a link; experimental protocols that
modify memory cell number or function in animals
that are then followed for tumor development will
be needed to explore this issue further. There is
some evidence that maintenance of immune func-
tion in aging mice by sequential repopulation by
bone marrow and thymus transplantation can di-
minish mortality risk in mice, but the effect was
seen only in the first half of the life span (27). The
correlation between humoral immunity and life
span in Biozzi backcross mice (22) is also consistent
with this reasoning. Tests to see whether high
CD4M levels predict poor responsiveness to im-
munogens in our genetically heterogeneous mice
would provide insight into the relationship be-
tween this T cell subset and levels of in vivo im-
munity.
A third possible explanation would connect
CD4M changes to life span by proposing that both
are timed in part by some underlying factor such
as a hypothetical rate of biological aging (28).
Some gerontologists have argued that the aging
process is too complex and multifactorial to be re-
duced to a single dimension (29-31), whereas oth-
ers (16, 32, 33) have argued that individual
members of a species might age at measurably dif-
ferent rates, which can be defined and validated in
an operationally useful way. One way to test these
ideas would be to see whether measurements of
age-sensitive tests in one physiological system-
such as the immune system-might predict the out-
come of tests in other systems such as, for example,
muscle function, accumulation of molecular dam-
age, or disease incidence. In one such study using
9- to 12-month-old UM-HET3 mice, high levels of
CD4M were found to be correlated with low muscle
strength and endurance (16); further work is
needed to determine whether these relationships
also apply to older animals and whether the muscle
function tests themselves predict life span. A sec-
ond study (33), using aging macaque monkeys,
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found that a composite variable-summarizing in-
formation on interindividual differences in several
age-sensitive measures in different physiological
systems-was influenced by blood antioxidant lev-
els, which in turn influenced disease susceptibility.
Data from these studies, although consistent with
the idea that it may be possible to define aging rate
in a useful way, are still fragmentary and inconclu-
sive. Further tests of correlations between age-sen-
sitive immune markers (such as CD4M) and the
extent of change in other age-sensitive domains
will help to support or refute this class of hy-
pothesis.
Our univariate regressions suggested that other T
cell subsets may also provide prognostic information
about life span, but the relationships were less strong
that that seen for CD4M, and none of the other im-
mune variables contributed significantly to the mul-
tiple regression equation. Analysis of a larger group
of mice might provide sufficient statistical power to
test these possible relationships more effectively. The
ability of the CD4P test to predict life span in male
mice, if it is replicated in an independent sample,
might potentially give information about immune
status beyond that available from CD4M measure-
ments. Levels and rates of change of CD4P cells are
correlated in UM-HET3 mice with CD8P cells, but
not with CD4M or CD4V cells (20). P-glycoprotein
expression subdivides the CD4 memory subset (9);
CD4 memory cells that do express P-glycoprotein fail
to respond in tissue culture tests of proliferation and
cytokine production (10, 11). It is therefore plausible
that high proportions of CD4P cells might lead to
poor immune responsiveness, an idea that can be
tested directly by immunization of mice that differ in
CD4P counts.
The UM-HET3 population was chosen for this
study rather than a more traditional inbred or Fl hy-
brid mouse strain for two principal reasons. First, we
hoped that conclusions would be more robust than
those obtained from a study of genetically identical
animals, and thus more likely to apply to other kinds
of mice and perhaps other species as well. Second,
we hoped that genetic differences among the mice
might influence both life span and T cell indices in
a coordinated way. Our preliminary analyses (A. U.
Jackson, R. A. Miller, and D. T. Burke, unpublished
data) indicate the presence of genetic variation in
UM-HETS mice with significant influence on
CD4M[18] and CD8P[18] levels, and it will be inter-
esting to see whether variation at these loci also pre-
dicts longevity.
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